Stock listing
LGVN Stock Price, News, Filings & Events — Longeveron Inc.
Selected listing: LGVN · NASDAQ · USD · US
This page tracks Longeveron Inc.'s LGVN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LGVN:NASDAQ. LGVN:NASDAQ is the stock-level entry point for investors researching Longeveron Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Longeveron Inc. is a public company traded under the ticker LGVN in the American market. The company has a market capitalization of approximately $19.65 million. Longeveron focuses on developing innovative therapies to address age-related and chronic health conditions.
- Ticker
- LGVN:NASDAQ
- Asset type
- Stock
- Market cap
- $26.9M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Longeveron Inc. LGVN:NASDAQ stock context
This page tracks Longeveron Inc.'s LGVN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LGVN:NASDAQ. LGVN:NASDAQ is the stock-level entry point for investors researching Longeveron Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Longeveron Inc. is a public company traded under the ticker LGVN in the American market. The company has a market capitalization of approximately $19.65 million. Longeveron focuses on developing innovative therapies to address age-related and chronic health conditions.
Latest news from Longeveron Inc.
Longeveron Appoints Nirav Jhaveri as Chief Financial Officer
August 19, 2026
Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update
August 12, 2026
Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition
August 11, 2026
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
August 3, 2026
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
July 23, 2026
Longeveron Inc. earnings calls
Longeveron Inc. (LGVN) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Longeveron Inc. (LGVN) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Longeveron Inc. (LGVN) Q4 2025 Earnings Call
March 17, 2026 · Replay with transcript and chapters
Longeveron Inc. (LGVN) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Longeveron Inc. (LGVN) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
Longeveron Inc. (LGVN) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Longeveron Inc.
Longeveron Inc. investor report
Review AI stock analysis and investor report context for LGVN:NASDAQ.
Longeveron Inc. company profile
View the public company page for Longeveron Inc. on 6ix.
Longeveron Inc. news
Read company news and market updates connected to Longeveron Inc..
Longeveron Inc. investor events
Find investor webinars, events, and replay context for Longeveron Inc..